
Bonnevie Pharma Private Limited
About Bonnevie Pharma Private Limited
Data last updated:
Bonnevie Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC184631. Its GSTIN is 27AADCB5162A1Z5 (Maharashtra).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veer Vinodkumar Dadhia and Neha Himesh Dadhia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road Borivali(West), Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.62 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net profit of ₹28.5 Lakh (net margin 77.8%) and EBITDA of ₹29.12 Lakh (EBITDA margin 79.5%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 39% over five years.
As per MCA filings, the company has open charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bonnevie Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB/302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road Borivali(West), Mumbai, Maharashtra, India – 400092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bonnevie Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bonnevie Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bonnevie Pharma Private Limited, buy the company report.
Financials of Bonnevie Pharma Private Limited
FY 2025 filings availableBonnevie Pharma Private Limited reported revenue of ₹36.62 Lakh (down 84% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 39% over five years, including a 84% fall in the latest year. EBITDA rose 203% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 79.5% | ||||
| Net Profit Margin | 77.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bonnevie Pharma Private Limited, buy the company report.
Board of directors of Bonnevie Pharma Private Limited
Bonnevie Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veer Vinodkumar Dadhia | Director | 14 Jul 2008 | 18 Years 3 Months | Current |
| Neha Himesh Dadhia | Director | 19 Nov 2022 | 3 Years 11 Months | Current |
Auditor
Bonnevie Pharma Private Limited is audited by Parekh & Co. for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Parekh & Co. | FY 2016 |
Shareholding
The shareholding of Bonnevie Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bonnevie Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Sep 2015 | 10598236 | Others | ₹24 Lakh | Open |
To see the full charge records of Bonnevie Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Bonnevie Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bonnevie Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bonnevie Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCB5162A1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bonnevie Pharma Private Limited, buy the company report.
Recent activity
Bonnevie Pharma Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Himesh Ramesh Dadhia ceased to be Director on 21 Nov 2022.
Frequently asked questions
Bonnevie Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 July 2008 (18+ years old) and is registered under CIN U24239MH2008PTC184631.
Bonnevie Pharma has 2 current directors:
- Veer Vinodkumar Dadhia - Director
- Neha Himesh Dadhia - Director
The latest financial statements of Bonnevie Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bonnevie Pharma is 27AADCB5162A1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bonnevie Pharma is U24239MH2008PTC184631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bonnevie Pharma was incorporated on 14 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
Himesh Ramesh Dadhia ceased to be Director on 21 Nov 2022. Neha Himesh Dadhia was appointed as Director on 19 Nov 2022. Santosh Deshpande ceased to be Director on 30 Oct 2009. Bonnevie Pharma has 4 board changes on record in total.
The registered office of Bonnevie Pharma is at B302 Jamana Darshan Chs Dr N. R. Korade Marg S. V. Road BorivaliWest, Mumbai, Maharashtra, India – 400092.
Bonnevie Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Bonnevie Pharma has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.

